|
1
|
Collins LG, Haines C, Perkel R and Enck
RE: Lung cancer: diagnosis and management. Am Fam Physician.
75:56–63. 2007.
|
|
2
|
American Cancer Society. Cancer facts
& figures 2012. American Cancer Society, Inc.; Atlanta:
2012
|
|
3
|
Ridley AJ, Schwartz MA, Burridge K, et al:
Cell migration: integrating signals from front to back. Science.
302:1704–1709. 2003.
|
|
4
|
Pollard TD and Borisy GG: Cellular
motility driven by assembly and disassembly of actin filaments.
Cell. 112:453–465. 2003.
|
|
5
|
Sossey-Alaoui K, Ranalli TA, Li X, Bakin
AV and Cowell JK: WAVE3 promotes cell motility and invasion through
the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res.
308:135–145. 2005.
|
|
6
|
Sossey-Alaoui K, Li X and Cowell JK:
c-Abl-mediated phosphorylation of WAVE3 is required for
lamellipodia formation and cell migration. J Biol Chem.
282:26257–26265. 2007.
|
|
7
|
Sossey-Alaoui K, Downs-Kelly E, Das M,
Izem L, Tubbs R and Plow EF: WAVE3, an actin remodeling protein, is
regulated by the metastasis suppressor microRNA, miR-31, during the
invasion-metastasis cascade. Int J Cancer. 129:1331–1343. 2011.
|
|
8
|
Sossey-Alaoui K, Safina A, Li X, Vaughan
MM, Hicks DG, Bakin AV and Cowell JK: Down-regulation of WAVE3, a
metastasis promoter gene, inhibits invasion and metastasis of
breast cancer cells. Am J Pathol. 170:2112–2121. 2007.
|
|
9
|
Teng Y, Ren MQ, Cheney R, Sharma S and
Cowell JK: Inactivation of the WASF3 gene in prostate cancer cells
leads to suppression of tumorigenicity and metastases. Br J Cancer.
103:1066–1075. 2010.
|
|
10
|
Teng Y, Liu M and Cowell JK: Functional
interrelationship between the WASF3 and KISS1 metastasis-associated
genes in breast cancer cells. Int J Cancer. 129:2825–2835.
2011.
|
|
11
|
Chen S, Zha X, Yang L, Li B, Liye Z and Li
Y: Deficiency of CD3gamma, delta, epsilon and zeta expression in
T-cells from AML patients. Hematology. 16:31–36. 2011.
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
13
|
Berx G, Raspé E, Christofori G, Thiery JP
and Sleeman JP: Pre-EMTing metastasis? Recapitulation of
morphogenetic processes in cancer. Clin Exp Metastasis. 24:587–597.
2007.
|
|
14
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008.
|
|
15
|
Savagner P: Leaving the neighborhood:
molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001.
|
|
16
|
Spaderna S, Schmalhofer O, Hlubek F, Jung
A, Kirchner T and Brabletz T: Epithelial-mesenchymal and
mesenchymal-epithelial transitions during cancer progression. Verh
Dtsch Ges Pathol. 91:21–28. 2007.
|
|
17
|
Nguyen DX and Massagué J: Genetic
determinants of cancer metastasis. Nat Rev Genet. 8:341–352.
2007.
|
|
18
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009.
|
|
19
|
Sossey-Alaoui K: Surfing the big WAVE:
Insights into the role of WAVE3 as a driving force in cancer
progression and metastasis. Semin Cell Dev Biol. 24:287–297.
2013.
|
|
20
|
Fernando HS, Sanders AJ, Kynaston HG and
Jiang WG: WAVE3 is associated with invasiveness in prostate cancer
cells. Urol Oncol. 28:320–327. 2010.
|
|
21
|
Kulkarni S, Augoff K, Rivera L, McCue B,
Khoury T, Groman A, et al: Increased expression levels of WAVE3 are
associated with the progression and metastasis of triple negative
breast cancer. PLoS One. 7:e428952012.
|
|
22
|
Zhang Y, Guan XY, Dong B, Zhao M, Wu JH,
Tian XY and Hao CY: Expression of MMP-9 and WAVE3 in colorectal
cancer and its relationship to clinicopathological features. J
Cancer Res Clin Oncol. 138:2035–2044. 2012.
|
|
23
|
Suetsugu S and Takenawa T: Regulation of
cortical actin networks in cell migration. Int Rev Cytol.
229:245–286. 2003.
|
|
24
|
Millard TH, Sharp SJ and Machesky LM:
Signalling to actin assembly via the WASP (Wiskott-Aldrich syndrome
protein)-family proteins and the Arp2/3 complex. Biochem J.
380:1–17. 2004.
|
|
25
|
Sossey-Alaoui K, Li X, Ranalli TA and
Cowell JK: WAVE3-mediated cell migration and lamellipodia formation
are regulated downstream of phosphatidylinositol 3-kinase. J Biol
Chem. 280:21748–21755. 2005.
|
|
26
|
Teng Y, Ngoka L, Mei Y, Lesoon L and
Cowell JK: HSP90 and HSP70 proteins are essential for stabilization
and activation of WASF3 metastasis-promoting protein. J Biol Chem.
287:10051–10059. 2012.
|
|
27
|
Condeelis J, Singer RH and Segall JE: The
great escape: when cancer cells hijack the genes for chemotaxis and
motility. Annu Rev Cell Dev Biol. 21:695–718. 2005.
|
|
28
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009.
|
|
29
|
Engel FB, Schebesta M, Duong MT, Lu G, Ren
S, Madwed JB, et al: p38 MAP kinase inhibition enables
proliferation of adult mammalian cardiomyocytes. Genes Dev.
19:1175–1187. 2005.
|
|
30
|
Hui L, Bakiri L, Stepniak E and Wagner EF:
p38alpha: a suppressor of cell proliferation and tumorigenesis.
Cell Cycle. 6:2429–2433. 2007.
|
|
31
|
Lee RJ, Albanese C, Stenger RJ, Watanabe
G, Inghirami G, Haines GK III, et al: pp60(v-src) induction of
cyclin D1 requires collaborative interactions between the
extracellular signal-regulated kinase, p38, and Jun kinase
pathways. A role for cAMP response element-binding protein and
activating transcription factor-2 in pp60(v-src) signaling in
breast cancer cells. J Biol Chem. 274:7341–7350. 1999.
|
|
32
|
Ricote M, García-Tuñón I, Bethencourt F,
Fraile B, Onsurbe P, Paniagua R and Royuela M: The p38 transduction
pathway in prostatic neoplasia. J Pathol. 208:401–407. 2006.
|
|
33
|
Recio JA and Merlino G: Hepatocyte growth
factor/scatter factor activates proliferation in melanoma cells
through p38 MAPK, ATF-2 and cyclin D1. Oncogene. 21:1000–1008.
2002.
|
